Drugs that contain Tadalafil
1. List of Tadliq drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11382917 | CMP DEV LLC | Liquid oral formulations for tadalafil |
Dec, 2038
(15 years from now) | |
Do you want to check out TADLIQ patents from before 2022?
Market Authorisation Date: 17 June, 2022
Treatment: Tadliq is indicated for the treatment of pulmonary arterial hypertension (pah) (who group 1) to improve exercise ability
Dosage: SUSPENSION;ORAL
More Information on Dosage
TADLIQ family patents
6
United States
2
India
1
IB
1
China
1
Brazil
1
Canada
1
Morocco
1
Singapore
1
Japan
1
Australia
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic